REGENXBIO Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	34.47	57.53	34.52	96.95	345.21
Short-Term Investments	195.6	177.16	240.74	267.69	112.23
Cash & Short-Term Investments	230.07	234.69	275.26	364.64	457.44
Cash Growth	-1.97%	-14.74%	-24.51%	-20.29%	-3.85%
Accounts Receivable	26.38	20.47	24.79	28.08	32.44
Other Receivables	2.31	0.47	0.7	1.5	2.26
Total Trade Receivables	28.69	20.95	25.49	29.59	34.7
Other Current Assets	24.83	22.84	34.92	23.25	28.95
Total Current Assets	281.28	278	334.97	415.98	518.83
Net Property, Plant & Equipment	152.01	171.31	192.59	206.8	192.45
Long-Term Investments	10.79	10.18	38.87	200.56	391.91
Other Long-Term Assets	6.64	6.03	6.84	8.43	8.46
Total Assets	453.03	465.99	573.97	833.27	1,114
Accounts Payable	21.36	22.8	22.79	27.21	11.39
Accrued Expenses	38.39	38.07	49.7	46.79	76.11
Current Portion of Long-Term Debt	39.61	34.31	50.57	48.6	37.89
Current Portion of Leases	8.29	7.9	7.07	6	1.75
Unearned Revenue	10.45	0.12	0.15	1.83	3.33
Total Current Liabilities	118.1	103.19	130.27	130.43	130.47
Long-Term Debt	147.41	25.38	43.49	89.01	133.46
Long-Term Leases	65.22	74.13	82.22	88.8	84.93
Other Long-Term Liabilities	19.58	3.64	6.25	8.83	0.75
Total Long-Term Liabilities	232.2	103.14	131.96	186.64	219.13
Total Liabilities	350.3	206.34	262.23	317.07	349.61
Common Stock	0.01	0.01	0	0	0
Additional Paid-in Capital	1,229	1,193	1,021	973.15	928.1
Accumulated Other Comprehensive Income	-0.69	-0.74	-4.43	-15.4	-2.57
Retained Earnings	-1,126	-932.15	-705.05	-441.55	-161.23
Shareholders' Equity	102.73	259.65	311.74	516.2	764.3
Total Liabilities & Equity	453.03	465.99	573.97	833.27	1,114
Total Debt	260.52	141.72	183.34	232.41	258.03
Net Cash (Debt)	-30.45	92.97	91.92	132.24	199.41
Net Cash Growth	-	1.14%	-30.49%	-33.69%	-4.95%
Net Cash Per Share	-0.59	1.88	2.10	3.06	4.54
Book Value	102.73	259.65	311.74	516.2	764.3
Book Value Per Share	1.99	5.24	7.13	11.96	17.40
Tangible Book Value	102.73	259.65	311.74	516.2	764.3
Tangible Book Value Per Share	1.99	5.24	7.13	11.96	17.40

Updated Mar 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q